People living with undiagnosed HIV infection and a low CD4 count: Estimates from surveillance data, Italy, 2012 to 2014
Regine, V., Dorrucci, M., Pezzotti, P., Mammone, A., Quinten, C., Pharris, A., Suligoi, B., Di Giacomo, M., Faggioni, V., Scancella, L., Locuratolo, F., Cauzillo, G., Mignuoli, A.D., Chirico, D.G., Borgia, G., Massimiliani, E., Gallo, T., Braida, C., Puro, V., Scognamiglio, P., Icardi, G., Lai, P.L., Gramegna, M., Coppola, L., Piatti, A., Rosa, A., Cereda, D., Filippetti, F., Prozzo, A., Pasqualini, C., Mian, P., Moling, O., Pagani, L., Lanzafame, P., Collini, L., Bassetti, D., Chironna, M., Palmas, M.A., Dardanoni, G., Voller, F., Puglia, M., Pecori, L., Tosti, A., Papili, R., Ruffier, M., Verardo, M.G., Echarlod, E.F., Amoroso, S., Russo, F., Da Re, F.
Effectiveness and cost-effectiveness of antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility
This literature review was conducted as part of a project evaluating the effectiveness of antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in EU/EEA Member States.
Antenatal screening approaches effective in preventing MTCT of HIV, HBV, syphilis and rubella in vulnerable populations
In order to collect evidence on effective types of antenatal screening intervention that are effective for population groups vulnerable to MTCT, a review of the existing published literature was performed.
Public health guidance on antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA – addressing the vulnerable populations
This publication aims to support the strengthening of antenatal screening programmes for HIV, hepatitis B, syphilis and rubella susceptibility in the general population and in groups identified as vulnerable to mother-to-child-transmission in the EU/EEA.
Antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA
This report is part of an ECDC project on the effectiveness of antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA.
Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA
This report presents the main findings of an ECDC project to assess the burden of infectious diseases among migrants in the EU/EEA based on available data for specific diseases: human immunodeficiency virus (HIV), tuberculosis (TB), hepatitis B, hepatitis C, gonorrhoea, syphilis, measles and rubella, malaria and Chagas disease.